KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Operating Margin (2016 - 2025)

Historic Operating Margin for Xenon Pharmaceuticals (XENE) over the last 11 years, with Q1 2025 value amounting to 969.84%.

  • Xenon Pharmaceuticals' Operating Margin changed N/A to 969.84% in Q1 2025 from the same period last year, while for Sep 2025 it was 4543.73%, marking a year-over-year change of. This contributed to the annual value of 1368.91% for FY2022, which is 9404600.0% down from last year.
  • As of Q1 2025, Xenon Pharmaceuticals' Operating Margin stood at 969.84%.
  • Xenon Pharmaceuticals' Operating Margin's 5-year high stood at 198.14% during Q1 2022, with a 5-year trough of 28884.85% in Q3 2022.
  • In the last 3 years, Xenon Pharmaceuticals' Operating Margin had a median value of 817.25% in 2021 and averaged 4762.84%.
  • Data for Xenon Pharmaceuticals' Operating Margin shows a peak YoY increase of 1703500bps (in 2022) and a maximum YoY decrease of -285382300bps (in 2022) over the last 5 years.
  • Xenon Pharmaceuticals' Operating Margin (Quarter) stood at 664.65% in 2021, then crashed by -4246bps to 28884.85% in 2022, then soared by 97bps to 969.84% in 2025.
  • Its Operating Margin stands at 969.84% for Q1 2025, versus 28884.85% for Q3 2022 and 5655.78% for Q2 2022.